By Benadeta Mwaura - Reporter
Kenya , June 19, 2026 - Cancer Care Kenya has nearly doubled its annual revenue to almost KSh1 billion, underlining the growing demand for specialised cancer treatment services in the country amid efforts to expand access to oncology care.
The company attributed the strong performance to rising patient numbers, increased uptake of advanced treatment options and the expansion of cancer care services across Kenya.
According to the firm's latest financial results, revenue rose significantly over the past year, reflecting increasing demand for diagnosis, treatment and follow-up care as Kenya grapples with a growing cancer burden.
Cancer remains one of the leading causes of death in Kenya, with the country recording an estimated 45,000 new cases annually and approximately 29,000 cancer-related deaths each year, according to the Ministry of Health.
The strong financial performance comes as the government ramps up investments in cancer care infrastructure under the Universal Health Coverage programme, including the decentralisation of oncology services and enhanced financing through the Social Health Authority.
Cancer Care Kenya operates the HCG CCK Cancer Centre in Nairobi in partnership with Indian oncology provider HealthCare Global Enterprises, which has been increasing its investment in the Kenyan business. HealthCare Global announced plans to raise its stake in Cancer Care Kenya to more than 90% following an additional investment of about KSh100 million.
The oncology provider said the growth reflects increased demand for comprehensive cancer services, including chemotherapy, radiation therapy, diagnostics and specialised consultations.
The expansion comes as the government works to strengthen regional cancer treatment capacity. Earlier this year, the Ministry of Health announced plans to expand cancer centres in major referral hospitals across the country, including facilities in Kisii, Mombasa, Garissa and Nakuru.
More from Kenya
Health Cabinet Secretary Aden Duale has said the government is committed to reducing cancer-related deaths through improved access to treatment and enhanced health financing.
"The Social Health Authority provides up to KSh550,000 annually for cancer diagnosis and treatment under SHIF and the Emergency, Chronic, and Critical Illness Fund," Duale said during the National Cancer Summit in Nairobi.
Despite recent gains, healthcare experts warn that late diagnosis remains a major challenge, with more than 70% of cancer cases in Kenya detected at advanced stages, increasing treatment costs and reducing survival rates.
The rising revenues recorded by Cancer Care Kenya highlight both the growing demand for specialised oncology services and the urgent need for continued investment in prevention, screening and treatment infrastructure to address Kenya's escalating cancer burden.